Open Access<p>Chemokine Ligand 5 to Predict Optimal Cytoreduction in Ovarian Cancer</p>
Author(s) -
Yudi Mulyana Hidayat,
Munizar,
Ali Budi Harsono,
Gatot Nyarumenteng Adhipurnawan Winarno,
- Hasanuddin,
Siti Salima
Publication year - 2020
Publication title -
international journal of general medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s280858
Subject(s) - medicine , ovarian cancer , surgery , stage (stratigraphy) , cytoreductive surgery , cancer , paleontology , biology
The ultimate goal of cytoreduction surgery is the complete removal of all visible tumors (complete cytoreductive surgery) or tumor residues <1 cm (optimal cytoreduction surgery). Following cytoreduction surgery in ovarian cancer, tumor residue is one of the most important prognostic factors. Oncologists strive to be able to predict the outcome of cytoreduction surgery during the presurgical period. The purpose of this study was to assess CCL5 as a modality for determining whether a patient could perform optimal cytoreduction surgery or not.